Exposure to ionizing radiation and development of bone sarcoma: New insights based on atomic-bomb survivors of Hiroshima and Nagasaki

Journal of Bone and Joint Surgery

Volumn 93, Issue 11, 2011, Pages 1008-1015

  Samartzis, Dino ^a   Nishi, Nobuo ^b   Hayashi, Mikiko ^b   Cologne, John ^b   Cullings, Harry M ^b   Kodama, Kazunori ^b   Miles, Edward F ^c   Funamoto, Sachiyo ^b   Suyama, Akihiko ^b   Soda, Midori ^b   Kasagi, Fumiyoshi ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATOMIC BOMB SURVIVOR; BONE MARROW; CLINICAL ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; IONIZING RADIATION; JAPAN; LATENT PERIOD; MALE; MORPHOLOGY; OSTEOSARCOMA; PELVIS CANCER; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION HAZARD; SURVIVAL; SURVIVAL RATE;

EID: 79961057827     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.J.00256     Document Type: Article

References (84)

1. Davidson T, Westbury G, Harmer CL. Radiation-induced soft-tissue sarcoma. Br J Surg. 1986;73:308-9. (Pubitemid 16051053)
2. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumors of soft tissue and bone. In: World Health Organization classification of tumors. Lyon: IARC Press; 2002.
3. Huvos AG, Woodard HQ, Cahan WG, Higinbotham NL, Stewart FW, Butler A, Bretsky SS. Postradiation osteogenic sarcoma of bone and soft tissues. A clinico-pathologic study of 66 patients. Cancer. 1985;55:1244-55. (Pubitemid 15143400)
4. Souba WW, McKenna RJ Jr, Meis J, Benjamin R, Raymond AK, Mountain CF. Radiation-induced sarcomas of the chest wall. Cancer. 1986;57:610-5. (Pubitemid 16164620)
5. Wiklund TA, Blomqvist CP, Räty J, Elomaa I, Rissanen P, Miettinen M. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer. 1991; 68:524-31.
6. Miller RW, Boice JD, Curtis RE. Bone cancer. In: Schottenfield D, Fraumeni JF, editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. p 946-58.
7. Boice JD Jr, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC, Austin DF, Bosch A, Cookfair DL, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res. 1988;116:3-55.
8. Boice JD Jr, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, Clarke EA, Coleman MP, Curtis RE, Flannery JT, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst. 1985;74:955-75. (Pubitemid 15062953)
9. Carnes BA, Groer PG, Kotek TJ. Radium dial workers: issues concerning dose response and modeling. Radiat Res. 1997;147:707-14. (Pubitemid 27247184)
10. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897-904. (Pubitemid 27137189)
11. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M, Travis LB. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484-94.
12. Fry SA. Studies of U.S. radium dial workers: an epidemiological classic. Radiat Res. 1998;150(5 Suppl):S21-9. (Pubitemid 28519048)
13. Hawkins MM. Second primary tumors following radiotherapy for childhood cancer. Int J Radiat Oncol Biol Phys. 1990;19:1297-301.
14. Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 2001;92:172-80. (Pubitemid 32623054)
15. Kleinerman RA, Boice JD Jr, Storm HH, Sparen P, Andersen A, Pukkala E, Lynch CF, Hankey BF, Flannery JT. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer. 1995;76:442-52.
16. Koshurnikova NA, Gilbert ES, Sokolnikov M, Khokhryakov VF, Miller S, Preston DL, Romanov SA, Shilnikova NS, Suslova KG, Vostrotin VV. Bone cancers in Mayak workers. Radiat Res. 2000;154:237-45.
17. Lewis CA, Smith PG, Stratton IM, Darby SC, Doll R. Estimated radiation doses to different organs among patients treated for ankylosing spondylitis with a single course of X rays. Br J Radiol. 1988;61:212-20. (Pubitemid 18061783)
18. National Academy of Sciences. Health risks of radon and other internally deposited alpha-emitters (BEIR IV report). Washington DC: Natl Acad Pr; 1988.
19. Tucker MA, D'Angio GJ, Boice JD Jr, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317:588-93. (Pubitemid 17126781)
20. Virtanen A, Pukkala E, Auvinen A. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer. 2006;118:1017-21. (Pubitemid 43157680)
21. Weiss HA, Darby SC, Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer. 1994;59:327-38.
22. Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278:1262-7. (Pubitemid 27435614)
23. Nekolla EA, Kreisheimer M, Kellerer AM, Kuse-Isingschulte M, Gössner W, Spiess H. Induction of malignant bone tumors in radium-224 patients: risk estimates based on the improved dosimetry. Radiat Res. 2000;153:93-103. (Pubitemid 30117088)
24. Polednak AP, Stehney AF, Rowland RE. Mortality among women first employed before 1930 in the U.S. radium dial-painting industry. A group ascertained from employment lists. Am J Epidemiol. 1978;107:179-95. (Pubitemid 8313528)
25. Rowland RE, Stehney AF, Lucas HF Jr. Dose-response relationships for female radium dial workers. Radiat Res. 1978;76:368-83. (Pubitemid 9069293)
26. Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK, Beral V, Cowper G, Douglas A, Fix J, et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res. 1995;142:117-32.
27. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Bernar J, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklöf M, Engels H, Engholm G, Gulis G, Habib RR, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res. 2007;167:396-416. (Pubitemid 351292972)
28. Bithell JF, Stewart AM. Pre-natal irradiation and childhood malignancy: a review of British data from the Oxford Survey. Br J Cancer. 1975;31:271-87.
29. Darby SC, Reeves G, Key T, Doll R, Stovall M. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer. 1994;56: 793-801. (Pubitemid 24102742)
30. Fürst CJ, Lundell M, Holm LE, Silfverswärd C. Cancer incidence after radiotherapy for skin hemangioma: a retrospective cohort study in Sweden. J Natl Cancer Inst. 1988;80:1387-92.
31. Inskip PD, Monson RR, Wagoner JK, Stovall M, Davis FG, Kleinerman RA, Boice JD Jr. Cancer mortality following radium treatment for uterine bleeding. Radiat Res. 1990;123:331-44. (Pubitemid 20327906)
32. Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lunberg LM, Wallgren A. Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol. 1995;34:735-40.
33. Kim JH, Chu FC, Woodard HQ, Melamed MR, Huvos A, Cantin J. Radiation-induced soft-tissue and bone sarcoma. Radiology. 1978;129:501-8. (Pubitemid 9003907)
34. Lee YY, Van Tassel P, Nauert C, Raymond AK, Edeiken J. Craniofacial osteosarcomas: plain film, CT, and MR findings in 46 cases. AJR Am J Roentgenol. 1988;150:1397-402.
35. Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, Diallo I, Vassal G, Bessa E, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Eschwège F, Chavaudra J, Lemerle J. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer. 1998;77:370-7. (Pubitemid 28299872)
36. Lorigan JG, Libshitz HI, Peuchot M. Radiation-induced sarcoma of bone: CT findings in 19 cases. AJR Am J Roentgenol. 1989;153:791-4. (Pubitemid 19243785)
37. Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, de Vathaire F. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat. 2005;89:277-88. (Pubitemid 43293076)
38. Sheppard DG, Libshitz HI. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol. 2001;56:22-9. (Pubitemid 32685180)
39. Smith J. Radiation-induced sarcoma of bone: clinical and radiographic findings in 43 patients irradiated for soft tissue neoplasms. Clin Radiol. 1982;33:205-21. (Pubitemid 12122296)
40. Sundaresan N, Huvos AG, Krol G, Hughes JE, Cahan WG. Postradiation sarcoma involving the spine. Neurosurgery. 1986;18:721-4. (Pubitemid 16067824)
41. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 2000 report to the General Assembly, with scientific annexes. Sources and effects of ionizing radiation. New York: United Nations; 2000.
42. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, part 2: some internally deposited radionuclides. Lyon, France: IARC Pr; 1999.
43. Leenhouts HP, Brugmans MJ. An analysis of bone and head sinus cancers in radium dial painters using a two-mutation carcinogenesis model. J Radiol Prot. 2000;20:169-88. (Pubitemid 30352914)
44. Unni KK. Dahlin's bone tumors: general aspects and data on 11,087 cases. Springfield: Lippincott-Raven; 1996.
45. Arlen M, Higinbotham NL, Huvos AG, Marcove RC, Miller T, Shah IC. Radiation-induced sarcoma of bone. Cancer. 1971;28:1087-99.
46. Kim JH, Chu FC, Woodward HQ, Huvos A. Radiation induced sarcomas of bone following therapeutic radiation. Int J Radiat Oncol Biol Phys. 1983;9:107-10. (Pubitemid 13195568)
47. Sim FH, Cupps RE, Dahlin DC, Ivins JC. Postradiation sarcoma of bone. J Bone Joint Surg Am. 1972;54:1479-89.
48. Weatherby RP, Dahlin DC, Ivins JC. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc. 1981;56:294-306. (Pubitemid 11082728)
49. Pendlebury SC, Bilous M, Langlands AO. Sarcomas following radiation therapy for breast cancer: a report of three cases and a review of the literature. Int J Radiat Oncol Biol Phys. 1995;31:405-10.
50. Rowland RE, Stehney AF, Lucas HF. Dose-response relationships for radium-induced bone sarcomas. Health Phys. 1983;44 Suppl 1:15-31.
51. Sagerman RH, Cassady JR, Tretter P, Ellsworth RM. Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med. 1969;105:529-35.
52. Mitchel RE, Jackson JS, Carlisle SM. Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res. 2004;162:20-30. (Pubitemid 39044715)
53. Kalra S, Grimer RJ, Spooner D, Carter SR, Tillman RM, Abudu A. Radiation-induced sarcomas of bone: factors that affect outcome. J Bone Joint Surg Br. 2007;89:808-13. (Pubitemid 47180203)
54. Young JW, Liebscher LA. Postirradiation osteogenic sarcoma with unilateral metastatic spread within the field of irradiation. Case report and review of the literature. Skeletal Radiol. 1982;8:279-83. (Pubitemid 12019085)
55. Mabuchi K, Soda M, Ron E, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL, Thompson DE. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 1994;137(2 Suppl):S1-16.
56. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168:1-64. (Pubitemid 351292925)
57. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res. 1994;137(2 Suppl):S17-67. (Pubitemid 24060246)
58. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003;160:381-407. (Pubitemid 37174507)
59. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 2004;161:622-32. (Pubitemid 39149570)
60. Ron E, Carter R, Jablon S, Mabuchi K. Agreement between death certificate and autopsy diagnoses among atomic bomb survivors. Epidemiology. 1994;5:48-56. (Pubitemid 24021115)
61. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, Kodama K. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res. 2004;162:377-89. (Pubitemid 39388159)
62. Preston DL, Lubin J, Pierce D, McConney M. Epicure users guide. Seattle: HiroSoft International Corporation; 1993.
63. Beck A. Zur Frage des Rontgensarkoms, zugleich ein Beitrag zur Pathogenese des Sarkoms. Munchener Med Wochenschr. 1922;69:623-5.
64. Martland H, Humphries R. Osteogenic sarcoma in dial painters using luminous paint. Arch Pathol. 1929;7:406-17.
65. Wang JX, Inskip PD, Boice JD Jr, Li BX, Zhang JY, Fraumeni JF Jr. Cancer incidence among medical diagnostic X-ray workers in China, 1950 to 1985. Int J Cancer. 1990;45:889-95. (Pubitemid 20179643)
66. Baverstock KF, Papworth D, Vennart J. Risks of radiation at low dose rates. Lancet. 1981;1:430-3. (Pubitemid 11188944)
67. Grimer RJ. Size matters for sarcomas! Ann R Coll Surg Engl. 2006;88:519-24. (Pubitemid 44596452)
68. McHugh JB, Thomas DG, Herman JM, Ray ME, Baker LH, Adsay NV, Rabah R, Lucas DR. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons. Cancer. 2006;107:554-62. (Pubitemid 44107216)
69. Maghami EG, St-John M, Bhuta S, Abemayor E. Postirradiation sarcoma: a case report and current review. Am J Otolaryngol. 2005;26:71-4. (Pubitemid 40038082)
70. Shaheen M, Deheshi BM, Riad S, Werier J, Holt GE, Ferguson PC, Wunder JS. Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res. 2006;450:76-81. (Pubitemid 44342118)
71. Brady MS, Gaynor JJ, Brennan MF. Radiation-associated sarcoma of bone and soft tissue. Arch Surg. 1992;127:1379-85.
72. Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol. 2000;75:42-50.
73. Brenner DJ, Curtis RE, Hall EJ, Ron E. Secondmalignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000;88:398-406. (Pubitemid 30051826)
74. Stovall M, Blackwell CR, Cundiff J, Novack DH, Palta JR, Wagner LK, Webster EW, Shalek RJ. Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys. 1995;22:63-82.
75. Pirzkall A, Carol M, Lohr F, Höss A, Wannenmacher M, Debus J. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys. 2000;48:1371-80.
76. Thilmann C, Sroka-Perez G, Krempien R, Hoess A, Wannenmacher M, Debus J. Inversely planned intensity modulated radiotherapy of the breast including the internal mammary chain: a plan comparison study. Technol Cancer Res Treat. 2004;3:69-75. (Pubitemid 38250470)
77. Pirzkall A, Carol MP, Pickett B, Xia P, RoachM 3rd, Verhey LJ. The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets. Int J Radiat Oncol Biol Phys. 2002;53:434-42. (Pubitemid 34522109)
78. Williams PO, Hounsell AR. X-ray leakage considerations for IMRT. Br J Radiol. 2001;74:98-100. (Pubitemid 32156638)
79. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol. 2006;176:1415-9. (Pubitemid 44307191)
80. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51:261-6. (Pubitemid 32758886)
81. Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M 3rd. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:654-62. (Pubitemid 44436693)
82. Howell RM, Ferenci MS, Hertel NE, Fullerton GD, Fox T, Davis LW. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT. Radiat Prot Dosimetry. 2005;115:508-12. (Pubitemid 43103473)
83. Howell RM, Hertel NE, Wang Z, Hutchinson J, Fullerton GD. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys. 2006;33:360-8. (Pubitemid 43183978)
84. Bechler JR, Robertson WW Jr, Meadows AT, Womer RB. Osteosarcoma as a second malignant neoplasm in children. J Bone Joint Surg Am. 1992;74:1079-83.